US FDA approves new once-daily oral HIV combination of doravirine/islatravir
21 April 2026. Related: Early access, Antiretrovirals.
Early access
US CDC stops testing services for key infectious diseases: rabies, mpox, measles, EBV, SARS and others
8 April 2026. Related: Early access, Activism & advocacy.
Psilocybin is 6-fold more effective than nicotine patches to stop smoking in pilot US study with CBT
7 April 2026. Related: Journal scan, Early access.
Update on Gilead’s once-weekly oral HIV GS-1720 and GS-4182 studies
2 April 2026. Related: Early access, Antiretrovirals.
BHIVA guidance on re-engaging people into HIV care
30 March 2026. Related: Early access, Treatment access.
GLP-1 receptor agonists reduce substance use disorder: a role for addiction to chemsex drugs?
6 March 2026. Related: Early access, Special reports, Side effects, Coinfections and complications.
Two cases of severe hyperglycemia with injectable CAB/RPV-LA
5 March 2026. Related: Journal scan, Early access, Side effects.